Louis S Krane, MDUrology
Dr Krane has published extensively in the urologic literature and his work has been selected to produce guidelines for urologic care. He has 50 peer reviewed articles in international journals, and has presented his work from Chile to Rome to Taiwain broadly throughout the United States. He has won numerous awards for his research including in 2009 at the national American Urologic Association (AUA) for providing patients a catheter less radical prostatectomy, in 2014 at the AUA for identifying which patients benefit from prostate cancer screening and in 2016 for drug repurposing in bladder cancer based on changes in gene expression from the American Society of Clinical Oncologists (ASCO). He’s part of a study funded by the congressionally directed medical research programs looking at return to work following prostate cancer therapy for African American men.
Here at Tulane, Dr Krane is specializing in personalized medicine for patients with urologic malignancies. His goal is to use new biomarkers, genomic classifications, epigenetic signatures, and imaging modalities to allow patients to receive patient care individualized to their tumor and produce improved cancer outcomes while minimizing the side effects of therapy. Dr Krane is recruiting patients for clinical trials and is currently accepting new patients.
- Urology - Primary
- Gender: Male
- Graduate Degree: Tulane University School of Medicine - 2007
- Internship: Wake Forest University - 2011
- Residency: Wake Forest University - 2015
- Fellowship: Vattikuti Urology Institute, Henry Ford Health Systems - 2009
- Fellowship: Wake Forest Institute of Regenerative Medicine - 2010
- Fellowship: National Cancer Institute, Department of Urology - 2017
- Tulane Medical Center
- Tulane Lakeside Hospital